Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

Follow-up CTC assessments strongly predict OS independently from tumor subtype and treatment. New randomized trials to define the clinical utility of CTC monitoring for risk stratification and as an early response marker in metastatic breast cancer are urgently needed.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-03-18
DOI
https://doi.org/10.1158/1078-0432.ccr-24-3108
Citations
9
Primary Topic
Cancer Cells and Metastasis
Type
article
Field-Weighted Citation Impact
9.41

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

Rafael López‐López, François‐Clément Bidard, Leon W.M.M. Terstappen, Brigitte Rack et al.
9 citations
Clinical Cancer Research
Cancer Cells and Metastasis
9.41
article

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

Rafael López‐López, François‐Clément Bidard, Leon W.M.M. Terstappen, Brigitte Rack, Jean‐Yves Pierga, Meredith M. Regan, Daniele Generali, Paola Gazzaniga, Minetta C. Liu, Markus Wallwiener, José Á. García-Sáenz, José Vidal-Martínez, Massimo Cristofanilli, Jeffrey B. Smerage, Tracy C. Yab, Elisabetta Munzone, Thomas W. P. Friedl, Luís Manso, Catherine Alix‐Panabières, Wolfgang Janni, Stefan Sleijfer, Klaus Pantel, Evi Lianidou, Kostandinos Sideras, Lisa A. Carey, William Jacot, Lorenzo Gerratana, Rafael Gisbert‐Criado, Simon A. Joosse, Michail Ignatiadis, Daniel F. Hayes, Mark Jesus M. Magbanua, Zefei Jiang, Luc Dirix, Sabine Riethdorf, Justin Stebbing, William E. Barlow, Tanja Fehm, Volkmar Mueller, Carlos Caldas, Hope S. Rugo, Karthik V. Giridhar, Dimitriοs Mavroudis
article en
9 citations

Abstract

Follow-up CTC assessments strongly predict OS independently from tumor subtype and treatment. New randomized trials to define the clinical utility of CTC monitoring for risk stratification and as an early response marker in metastatic breast cancer are urgently needed.

Clinical Cancer ResearchVol. 31(11)
University of North Carolina at Chapel Hill (US), University of Udine (IT), Université Libre de Bruxelles (BE), Mayo Clinic (US), University of Trieste (IT), University of Antwerp (BE), Inserm (FR), Universität Hamburg (DE), University of California, San Francisco (US), Université de Versailles Saint-Quentin-en-Yvelines (FR), National and Kapodistrian University of Athens (GR), Université Paris Cité (FR), Cornell University (US), Heidelberg University (DE), University of Cambridge (GB), University of Michigan (US), Jacksonville College (US), Institut Jules Bordet (BE), Erasmus MC (NL), WinnMed (US), Chinese PLA General Hospital (CN), Hospital Clínico San Carlos (ES), Düsseldorf University Hospital (DE), Cancer Research UK Cambridge Center (GB), Centre Hospitalier Universitaire de Montpellier (FR), GZA Ziekenhuizen Campus Sint-Augustinus (BE), 307th Hospital of Chinese People’s Liberation Army (CN), Cancer Research And Biostatistics (US), Hospital Universitario 12 De Octubre (ES), University Medical Center Hamburg-Eppendorf (DE), Michigan United (US), Michigan Medicine (US), Dana-Farber Cancer Institute (US), Michigan Center for Translational Pathology (US), Hospital Arnau de Vilanova (ES), National Cancer Institute (UA), Natera (United States) (US), Mayo Clinic in Arizona (US), University Hospital of Heraklion (GR), Institut de Recherche en Cancérologie de Montpellier (FR), Mayo Clinic in Florida (US), Instituto de Investigación Sanitaria de Santiago (ES), Erasmus MC Cancer Institute (NL), University Hospital in Halle (DE), University Hospital Ulm (DE), Centro de Investigación Biomédica en Red de Cáncer (ES), Azienda Sanitaria Universitaria Integrata di Trieste (IT), Weill Cornell Medicine (US), Institut Regional du Cancer de Montpellier (FR), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Heinrich Heine University Düsseldorf (DE), Anglia Ruskin University (GB), European Institute of Oncology (IT), Institut Curie (FR), Heidelberg University (US), Sapienza University of Rome (IT), University of Twente (NL)
Menarini Silicon Biosystems
Good health and well-being
Openalex Percentile: Top 2%
Cancer Cells and Metastasis
9.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.